Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Business Secretary Greg Clark has today launched the £103m Rosalind Franklin Institute (RFI), a national centre of excellence that will harness disruptive technologies such as AI and robotics to improve dramatically our understanding of biology.

An artist's impression of the new Rosalind Franklin Institute hub. Image courtesy of IBI

The development of the RFI was spearheaded by Oxford's Pro-Vice-Chancellor for Research and Innovation, Professor Ian Walmsley. Oxford will be one of ten partner universities working alongside the Science and Technology Facilities Council (STFC) to deliver the research, which will tackle many of the key challenges in the health and life sciences.

Among the initial projects funded today is the creation of the world's most advanced ultra-fast video camera, which will help researchers develop techniques that use sound and light to detect and treat diseases including some of the most lethal forms of cancer. Led by Oxford's Professor Eleanor Stride, the project is exploring targeted ways of treating cancer that can avoid the side effects of traditional treatments such as chemotherapy.

Find out more (University of Oxford website)

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.